Compare COGT & RUSHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COGT | RUSHB |
|---|---|---|
| Founded | 2014 | 1965 |
| Country | United States | United States |
| Employees | N/A | 7355 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.9B |
| IPO Year | 2018 | N/A |
| Metric | COGT | RUSHB |
|---|---|---|
| Price | $39.57 | $78.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $36.21 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 94.9K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,871,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,733.58 | $5.44 |
| P/E Ratio | ★ N/A | $16.53 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.38 | $47.71 |
| 52 Week High | $43.73 | $79.13 |
| Indicator | COGT | RUSHB |
|---|---|---|
| Relative Strength Index (RSI) | 56.60 | 67.99 |
| Support Level | $36.09 | $73.26 |
| Resistance Level | $40.67 | N/A |
| Average True Range (ATR) | 1.73 | 2.36 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 65.50 | 85.97 |
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.